Format

Send to

Choose Destination
See comment in PubMed Commons below
J Formos Med Assoc. 2013 Nov;112(11):707-12. doi: 10.1016/j.jfma.2012.06.002. Epub 2012 Aug 1.

Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.

Author information

1
Medical Molecular Genetics Department, National Research Center, Giza, Egypt. Electronic address: mlessawi@yahoo.com.

Abstract

BACKGROUND/PURPOSE:

Noonan syndrome (NS) is inherited as an autosomal dominant disorder with dysmorphic facies, short stature, and cardiac defects, which can be caused by missense mutations in the protein tyrosine phosphatase nonreceptor type 11 (PTPN11) gene, which encodes src homology region 2 domain containing tyrosine phosphatase-2 (SHP-2), a protein tyrosine phosphatase that acts in signal transduction downstream to growth factors and cytokines. The current study aimed to study the molecular characterization of the PTPN11 gene among Egyptian patients with Noonan syndrome.

METHODS:

Eleven exons of the PTPN11 gene were amplified and screened by single stranded conformational polymorphism (SSCP). DNA samples showing band shift in SSCP were subjected to sequencing.

RESULTS:

Mutational analysis of the PTPN11 gene revealed T→C transition at position 854 in exon 8, predicting Phe285Ser substitution within PTP domain of SHP-2 protein, in one NS patient and -21C→T polymorphism in intron 7 in four other cases.

CONCLUSION:

Knowing that NS is phenotypically heterogeneous, molecular characterization of the PTPN11 gene should serve to establish NS diagnosis in patients with atypical features, although lack of a mutation does not exclude the possibility of NS.

KEYWORDS:

Egyptian patients; Noonan syndrome; PTPN11; SHP-2; mutational analysis

PMID:
24183200
DOI:
10.1016/j.jfma.2012.06.002
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center